Stylus Medicine
Gene editing platform for inserting large genetic sequences into the genome
- Sector
- Biotech
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 12 pending
Capital timeline
No federal awards or Form D filings are on record for this company.
Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.
Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards
Founder? Add funding contextFounders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 12- PendingLarge Serine Recombinases And Systems And Uses ThereofUSPTOApplication PCTUS2025045426
- PendingCgas-sting Pathway Inhibitors And Uses ThereofUSPTOApplication PCTUS2025034638
- PendingLarge Serine Recombinases And Systems And Uses ThereofUSPTOApplication 63805155
Show all 12 patent records
- Large Serine Recombinases And Systems And Uses ThereofApplication PCTUS2025045426Pending
- Cgas-sting Pathway Inhibitors And Uses ThereofApplication PCTUS2025034638Pending
- Large Serine Recombinases And Systems And Uses ThereofApplication 63805155Pending
- Non-viral Circular Single-stranded Dna Systems And Uses ThereofApplication PCTUS2025019405Pending
- Non-Viral Circular Single-Stranded DNA Systems and Uses ThereofApplication 63744082Pending
- Large Serine Recombinases And Systems And Uses ThereofApplication 63744045Pending
- Non-Viral Circular Single-Stranded DNA Systems and Uses ThereofApplication 63742280Pending
- Non-Viral Circular Single-Stranded DNA Systems and Uses ThereofApplication 63697179Pending
- Large Serine Recombinases and Circular Single-Stranded DNA Systems and Uses ThereofApplication 63692318Pending
- Large Serine Recombinases And Systems And Uses ThereofApplication 63692537Pending
- cGAS-STING PATHWAY INHIBITORS AND USES THEREOFApplication 63662849Pending
- Large Serine Recombinases and Circular Single-Stranded DNA Systems and Uses ThereofApplication 63564361Pending
Related companies, and why
- ASTERO ERADO INCSimilar federal contract value in Biotech · null in contracts
- CONIFER POINT PHARMACEUTICALS, LLCSimilar federal contract value in Biotech · null in contracts
- Turning Point TherapeuticsSimilar federal contract value in Biotech · null in contracts
- HYKU BIOSCIENCES INC.Similar federal contract value in Biotech · null in contracts
- HUMACYTE, INC.Similar federal contract value in Biotech · null in contracts
- NEKTAR THERAPEUTICSSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .